NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Korio, Inc.

Korio, Inc.

Private
Doylestown, PennsylvaniaHealthcare & Life Scienceshttps://www.korioclinical.com/

Last Round

Series A

Sep 10, 2024

Est. Valuation

$17M

Total Funding Raised

$12.3M

Company Overview

Korio, Inc. is a healthtech company that provides a technology-first Randomization & Trial Supply Management (RTSM) platform for clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Pharma Supply Chain, Compliance, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

randomization and trial supply managementRTSMinteractive response technologyIRTclinical trial softwareclinical supply chaineClinicalclinical trial managementmid-study migrationtrial protocol changesclinical trial logisticsvertical SaaSaudit-readinessCRO softwarepharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Korio, Inc. Comps

Public and private peers based on sector, stage, and business model.

Korio, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Korio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 10, 2024
SeedOct 10, 2023

Key People

Founding team and executive leadership

Chuck Harris

Founder, COO

Founding Team

Ryan Keane

Founder, CEO

Founding Team

Korio, Inc. Investors

Notable investors and investment history

Korio, Inc. investors
InvestorRounds
BIP VenturesSeries A
Boston Millennia PartnersSeries A, Seed
Excelerate Health VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2025

    Jonathan Andrus joins the Board of Directors.

Korio, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Korio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Korio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDoylestown, Pennsylvania
Employee Range34
Year Founded2021
Last FundingSep 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.